HIV infection and Osteomalacia: when all is not due to HIV
Keywords:
Vitamin D, osteomalacia, HIV infectionAbstract
Osteomalacia caused by vitamin D deficiency, is an osteometabolic disease, not frequent in Portugal. The disease has
several aetiologies and assumes special importance in patients
with multiple risk factors. Due to the difficulty in identifying the
disease, a high level of suspicion is required in order to make the diagnosis.
We described the clinical case of a 33 year-old man, infected
with human immunodeficiency virus (HIV), with progressive
multifocal leukoencephalopathy for 6 years. The patient was
partially dependent for daily living activities and was admitted
for aetiological evaluation of bone pain and decreased muscular
strength, progressively intensifying over the course of one year.
Abnormal images were seen on a bone scan.
The evidence of multiple risk factors for vitamin D deficiency,
the presence of hypophosphatemia and imaging issues, raised
the suspicion of osteomalacia due to vitamin D deficiency. This
diagnosis was confirmed: analytically (low level of vitamin D
metabolites), histologically and by therapeutic response.
A brief review is made of the factors influencing vitamin D bone
metabolism and their importance in maintaining a proper immunological response. It is mentioned that the absence of clinical
suspicion may be responsible for many undiagnosed cases.
In patients infected with HIV who present with an obscure
clinical picture, we should also consider pathological entities not
directly in relation to immunodeficiency, as they may be treated and have a better prognosis.
Downloads
References
Leonard J, Deftos, MD, JD. Osteomalacia and Rickets In Clinical Essentials of Calcium and Skeletal Disorders. 1998 PCI; Ch 7.
Susana A. Dietary and Nutritional Influences on Skeletal Health – A Review of Current knowledge and Future Perspectives. Presented at the 22nd American Society for Bone and Mineral Research, Canada 2000.
Haug C, Muller F, Froland SS, Degre M, Aukrust P. Serum level of Vitamin D3 correlates with the degree of immune deficiency in HIV infection; Presented at the Int Conf AIDS 1993; 9 (1):197.
Haug C, Muller F, Froland SS, Degre M, Aukrust P. Severe deficiency of 1,25 dihidroxyvitamin D3 in human immunodeficiency vurus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998; 83 (11): 3832-3838.
Haug C, Muller F, Rollag H, Aukrust P, Degre M, Froland SS. The effect of 1,25 Vitamin D3 on maturation of monocytes from HIV infected patients varies with degree of immunodeficiency. APMIS 1996; 104 (7-8): 539-548.
Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE. Accelerated bone mineral loss in HIV infected patients receiving potent antiretroviral therapy. AIDS 2000; 14 (4): F63-67.
Susana A. Bone Fragility and Risk of Fracture – Current Concepts and Implications for Clinical Practice presented in World Congress on Osteoporosis. June 2000.
D’Erasmo E, Ragno A, Raejntroph N, Pisani D. Drug induced osteomalacia. Recenti Prog Med 1998; 89 (10):529-533.
Jeffrey Laurence. Accelerated Bone Mineral Loss in HIV – Positive Patients. The AIDS Reader 2000; 10 (4):192-200.
Gennari C. Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutrition 2001; 4 (2B): 547-559.
John H Klippel, Paul A Dieppe. Rheumatology. Second Edition Mosby 1998; Volume four.
Judith S. Currier. Metabolic Complications of Antiretroviral Therapy and HIV Infection. Medscape HIV/AIDS: Annual Update 2001
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna